Physician profile
Ellen Garibaldi
NPI 1770588535
$1,797.41
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $843 · 2021: $658 · 2022: $50.22.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $464.81 | 2019-2022 | |
| Optinose US, INC. | $215.50 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $131.62 | 2021 | |
| Glaxosmithkline, LLC. | $120.34 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $118.38 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.52 | 2020-2021 | |
| Genentech USA, INC. | $107.89 | 2019-2021 | |
| Alk-Abello, INC | $90.60 | 2019-2021 | |
| Pfizer INC. | $82.48 | 2019-2021 | |
| Genzyme Corporation | $71.55 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.84 | 2020-2021 | |
| Shire North American Group INC | $37.10 | 2019 | |
| Octapharma USA, INC. | $34.21 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $32.29 | 2020-2021 | |
| Boston Scientific Corporation | $25.44 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $24.85 | 2020 | |
| Horizon Therapeutics Plc | $20.85 | 2019 | |
| Bio Products Laboratory USA, INC. | $18.78 | 2020 | |
| Kaleo, INC. | $15.18 | 2020 | |
| Grifols USA, LLC | $11.18 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Garibaldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.